Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
A Randomized, Double-Blind Comparison of Oral Aprepitant and Lower Dose Dexamethasone vs Aprepitant Alone for Preventing Postoperative Nausea and Vomiting After Elective Laparoscopic Surgeries
Sponsor: Drexel University College of Medicine
This NA trial investigates Nausea and Vomiting and is currently ongoing. Drexel University College of Medicine leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2022 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2021 — Jun 2022 [monthly]
Unknown Status NA
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status NA
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Drexel University College of Medicine
- Main Line Health
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .